Long-term Outcomes for Acute Myeloid Leukemia Patients (1621-QLG-LG)

Gruppo Italiano Malattie EMatologiche dell'Adulto

Status: Unknown

Conditions: Acute Myeloid Leukemia

Treatments: Other: Questionnaire

Study type: Observational

Funder types: Other; NETWORK

Identifiers

NCT03755856

GIMEMA-EORTC 1621-QLG-LG

Details and patient eligibility

About

This international observational study aims at examining the patterns of health-related quality of life differences between long-term acute myeloid leukemia patients and their healthy peers from the general population.

Enrollment: 343 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of all subtypes of de novo AML, according to WHO criteria (at least 20% blasts in the bone marrow), except acute promyelocytic leukemia (APL).
• Age at AML diagnosis ≥ 18 years,
• Date of AML diagnosis at least 5 years before study enrollment,
• AML-free status at study enrollment,
• Written informed consent provided.

Exclusion criteria

• Major cognitive deficit or psychiatric problems hampering a self-reported evaluation,
• Not speaking and reading the language of the participating country,
• More than 75 years at the time of study enrollment,
• Receiving any active treatment for AML at the time of study enrollment.